HRMS using a Q-Exactive series mass spectrometer for regulated quantitative bioanalysis: how, when, and why to implement.
about
Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers.Liquid chromatography-high-resolution mass spectrometry for regulated bioanalysis: bile acid and oligonucleotide quantitation as a reference.2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS).Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.
P2860
HRMS using a Q-Exactive series mass spectrometer for regulated quantitative bioanalysis: how, when, and why to implement.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@en
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@nl
type
label
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@en
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@nl
prefLabel
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@en
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@nl
P2093
P2860
P356
P1433
P1476
HRMS using a Q-Exactive series ...... w, when, and why to implement.
@en
P2093
Barry R Jones
Daniel E Mulvana
Robert M Sturm
Steve Lowes
P2860
P304
P356
10.4155/BIO-2016-0079
P577
2016-07-27T00:00:00Z